Oxalis Group Limited has been acquired by Eaton Corporation
The private shareholders of Oxalis Group Limited have sold the company to Eaton Corporation for an undisclosed consideration.
Oxalis Group is engaged in the design, certification, manufacture and distribution of telecommunication products and solutions for use in extreme oil, gas and marine related environments. Solutions include closed-circuit TV camera stations, public address/general alarm systems and other electrical products that protect and safeguard assets, infrastructure and people.
Eaton provides energy-efficient solutions that help customers to effectively manage electrical, hydraulic and mechanical power more efficiently, safely and sustainably.
Oaklins Cavendish, based in the UK, advised the shareholders of Oxalis Group on the sale of the business to Eaton Corporation.


Talk to the deal team
Related deals
BodhiCedric has acquired Network Media from Jellysmack
The media holding company BodhiCedric has acquired Network Media, an innovator in the creator economy, from Jellysmack, the global creator company.
Learn moreCustomerXPs Software (Clari5) has been acquired by Perfios Software Solutions
Bengaluru-based SaaS firm Perfios Software Solutions Private Ltd. has acquired 100% of the equity shares in the fraud-detection platform CustomerXPs Software Private Ltd. (Clari5) for an undisclosed amount, enhancing its anti-financial crime management suite for financial institutions.
Learn moreBayer AG has entered into a takeover agreement with Cara Care
Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.
Learn more